Target intelligence / Profile preview

Septin 14 pseudogene 22 (SEPTIN14P22)

Target
SEPTIN14P22
Molecular classification
Pseudogene, Non-protein coding RNA, lncRNA pseudogene
01

Overview

Septin 14 pseudogene 22 (SEPTIN14P22) is a non-protein-coding pseudogene, annotated as ENSG00000248792[1]. It is classified as a long noncoding RNA (lncRNA) pseudogene located in the human genome, and is termed by several aliases including NCRNA00266-2P, LINC00266-2P, and others. Pseudogenes such as SEPTIN14P22 are generally considered non-functional remnants of once-active genes; this particular locus does not encode an active protein and there is no available evidence supporting a biological or disease-related function, nor any direct interaction with drugs or clinical biomarkers[1]. The name reflects homology with the septin family—a group of GTP-binding proteins involved in cell division, cytoskeletal organization, and other fundamental processes in functional forms[2][3]. However, pseudogenes like SEPTIN14P22 do not produce active proteins, and the septin protein functions described in the literature do not apply to this pseudogene. There is no evidence that pseudogenes of the septin family are currently considered therapeutic targets or that SEPTIN14P22 plays a role in human disease or therapy.

Other names
NCRNA00266-2PNCRNA00266BNCRNA00266YNCRNA00266Y1non-protein coding RNA 266-2pseudogenenon-protein coding RNA 266BLINC00266-2P

Beyond the preview

Go deeper on Septin 14 pseudogene 22 (SEPTIN14P22).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Septin 14 pseudogene 22 (SEPTIN14P22).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call